Cartesian Therapeutics, Inc.

CIK 1453687 · 877 filings in 46 form types · 2009-01-05 to 2026-11-06 · RNAC

Former names: SELECTA BIOSCIENCES INC

FiledFormCategory8-K items / descriptionAccession
2026-11-06 SCHEDULE 13G/A Ownership 0000312069-26-000266
2026-11-05 10-Q Financial reports 10-Q 0001453687-26-000111
2026-11-05 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001453687-26-000110
2026-09-29 8-K Current reports 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001453687-26-000105
2026-08-13 SCHEDULE 13G Ownership 0000312069-26-000206
2026-08-06 10-Q Financial reports 10-Q 0001453687-26-000101
2026-08-06 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001453687-26-000100
2026-07-22 SCHEDULE 13G/A Ownership 0000019617-26-000272
2026-06-17 8-K Current reports 5.07 Submission of Matters to a Vote of Security Holders 0001453687-26-000090
2026-06-09 144 Ownership 0001950047-26-005808
2026-06-09 8-K Current reports 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001140361-26-024556
2026-06-02 144 Ownership 0001950047-26-005471
2026-05-26 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001453687-26-000087
2026-05-06 SCHEDULE 13G/A Ownership 0000315066-26-001134
2026-04-30 S-8 Registrations and prospectuses 0001453687-26-000084
2026-04-30 10-Q Financial reports 10-Q 0001453687-26-000082
2026-04-30 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001453687-26-000081
2026-04-28 DEF 14A Proxies 0001453687-26-000072
2026-04-28 DEFA14A Proxies 0001453687-26-000071
2026-04-06 4 Ownership 0002064832-26-000149
2026-04-06 4 Ownership 0002064832-26-000148
2026-04-02 SCHEDULE 13D/A Ownership 0001193125-26-140633
2026-03-30 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0001453687-26-000068
2026-03-13 SCHEDULE 13G Ownership 0001642575-26-000003
2026-03-13 4 Ownership 0001453687-26-000066
2026-03-09 10-K Financial reports 10-K 0001453687-26-000064
2026-03-09 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001453687-26-000063
2026-02-05 SCHEDULE 13G/A Ownership 0000315066-26-000393
2026-01-13 144 Ownership 0001950047-26-000366
2026-01-09 144 Ownership 0001950047-26-000312
2026-01-09 8-K Current reports 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001453687-26-000051
2026-01-08 4 Ownership 0001453687-26-000047
2026-01-08 4 Ownership 0001453687-26-000046
2026-01-08 4 Ownership 0001453687-26-000045
2026-01-06 4 Ownership 0001453687-26-000039
2026-01-06 4 Ownership 0001453687-26-000038
2026-01-06 4 Ownership 0001453687-26-000037
2026-01-06 4 Ownership 0001453687-26-000036
2026-01-06 4 Ownership 0001453687-26-000035
2026-01-06 4 Ownership 0001453687-26-000034
2026-01-06 4 Ownership 0001453687-26-000033
2026-01-06 4 Ownership 0001453687-26-000032
2026-01-06 4 Ownership 0001453687-26-000031
2026-01-06 4 Ownership 0001453687-26-000030
2026-01-06 4 Ownership 0001453687-26-000029
2026-01-06 4 Ownership 0001453687-26-000028
2026-01-02 4 Ownership 0001453687-26-000002
2025-12-18 4 Ownership 0001453687-25-000144
2025-12-18 3 Ownership 0001453687-25-000143
2025-12-18 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.05 Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001453687-25-000140